Molecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic target
about
Relationships between chronic obstructive pulmonary disease and lung cancer: biological insightsEnvironmental immune disruptors, inflammation and cancer riskAssessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge aheadAnti-Inflammatory Properties of Flavone di-C-Glycosides as Active Principles of Camellia Mistletoe, Korthalsella japonicaRegulation of 5-oxo-ETE synthesis by nitric oxide in human polymorphonuclear leucocytes upon their interaction with zymosan and Salmonella typhimuriumDeveloping an irreversible inhibitor of human DDAH-1, an enzyme upregulated in melanoma.In Vitro Antileukemic Activity of Xanthosoma sagittifolium (Taioba) Leaf Extract.Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations.A reactive oxygen species activation mechanism contributes to JS-K-induced apoptosis in human bladder cancer cells.ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors.Molecular mechanisms of flavonoids in melanin synthesis and the potential for the prevention and treatment of melanomaInflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma.REDOX IMBALANCE IN LUNG CANCER OF PATIENTS WITH UNDERLYING CHRONIC RESPIRATORY CONDITIONS.Inflammatory factors of the tumor microenvironment induce plasticity in nontransformed breast epithelial cells: EMT, invasion, and collapse of normally organized breast texturesTargeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges.Mechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications.Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma.β3-adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling.Classifying the evolutionary and ecological features of neoplasms.Angiogenic factors are increased in circulating granulocytes and CD34+ cells of myeloproliferative neoplasms.Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy.
P2860
Q28077681-B3C54D2B-6B64-42ED-8179-96C1DE76F124Q28080870-04D79A78-FD1B-43B1-A8B6-58D87543A0D1Q28397132-6BB89053-2BE0-4007-BB43-0521E9DC1A88Q28821980-E0FC1B59-DFC7-45FE-9D83-4264C8411983Q33652655-D996EA46-6091-4DEF-AC4B-4E4BEE4C3430Q35031641-B9A55C45-5823-4CE8-8B90-0CF0FAF0671CQ35768770-F8A38870-28FE-4E4A-B204-D654812CA75BQ35869292-B5695C3D-CD9E-4547-A72C-5F3A1A8B0EEBQ36149908-E02DEA39-A0E0-4FDB-8286-C1B27D1D52AAQ36619606-294284BF-4426-41E7-A71E-72A6D9CFA6D6Q36989431-4B122C01-CB09-4690-A61E-E98DBBE712C9Q37014210-CB575E6C-76D7-4984-A7E2-7E04B6648591Q37217006-3F385FFC-1D40-4D7B-A417-309E5FA0AAE7Q37448056-80C7DA76-3876-4198-A1F1-31492070E980Q38181070-4C34B545-7A92-4290-9D3B-2EF39D4F1946Q38196881-1D4F8809-6971-491F-8891-945EFE2AA2A1Q38756385-55D2A46F-3890-46AC-BC4B-2EB398B3C380Q41514095-02A44B19-3572-48BF-9623-0DDB9AED24F3Q42455230-9FBCCB5D-6D65-41AC-86EA-71B06100DEB6Q45067426-7CF1B292-F672-4465-A999-CC66DD97F61FQ51683675-A8E03AD5-1818-425A-B26A-E60EDD2CEDE6Q52332683-363817A3-4119-4AD0-91A7-429386DD63DC
P2860
Molecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic target
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Molecular pathways: inflammati ...... a potential therapeutic target
@ast
Molecular pathways: inflammati ...... a potential therapeutic target
@en
Molecular pathways: inflammati ...... a potential therapeutic target
@nl
type
label
Molecular pathways: inflammati ...... a potential therapeutic target
@ast
Molecular pathways: inflammati ...... a potential therapeutic target
@en
Molecular pathways: inflammati ...... a potential therapeutic target
@nl
prefLabel
Molecular pathways: inflammati ...... a potential therapeutic target
@ast
Molecular pathways: inflammati ...... a potential therapeutic target
@en
Molecular pathways: inflammati ...... a potential therapeutic target
@nl
P2093
P2860
P3181
P1476
Molecular pathways: inflammati ...... a potential therapeutic target
@en
P2093
Andrew G Sikora
Elizabeth A Grimm
Suhendan Ekmekcioglu
P2860
P304
P3181
P356
10.1158/1078-0432.CCR-12-1554
P407
P577
2013-10-15T00:00:00Z